Unique Device Identifier (UDI)
/*li,
#main-content ul>li{
font-size:16px
}
/*]]>*/
/*
Supply chain attributes inform critical supply availability and alignment with internal and external needs, integral to meeting pressures to deliver safe care.
Dick Perrin of AHRMM’s Learning UDI Community (LUC) discusses the atomization and use of the same UDI across the continuum.
Consider the historical path of the Unique Device Identifier (UDI) currently hovering at its real-time usage and the resulting in cost savings and patient safety improvements. Dick Perrin of AHRMM’s Learning UDI Community (LUC) discusses the atomization and use of the same UDI across the continuum…
The AHRMM LUC members submitted comments and recommendations to the FDA's Draft Guidance for Select Updates for Unique Device Identification: Policy Regarding Global Unique Device Identification Database Requirements for Certain Devices. They recommend that information related to all Class I…
The UDI-DI Change Communication Process Work Group, a part of AHRMM's Learning UDI Community (LUC), recently released a report analyzing current communication processes and their implications on all stakeholders related to changes to the UDI-DI. Gain a clear understanding of how these changes are…
The UDI Impacts on Recall Management Work Group, a part of AHRMM's Learning UDI Community (LUC), has released their recommended practices reports that analyzes the barriers and highlights the benefits to patient safety and key stakeholder groups when utilizing the UDI throughout the recall process…
The AHRMM LUC members submitted public comments and recommendations at the FDA's November 2020 meeting related to the need to include the UDI in the recall process. They highlighted the prototype recall database and electronic submission form, as well as survey data supporting its creation.
Building UDI into Longitudinal Data for Medical Device Evaluation (BUILD) Point of Care Capture of UDI for Implantable Devices final summary report and roadmap.
In September 2019, FDA announced its Technology Modernization Action Plan (TMAP).
The TMAP describes important near-term actions that FDA is taking to modernize use of technology—computer hardware, software, data and analytics—to advance FDA’s public health mission. The TMAP will provide a…